Business Description
Sirona Biochem Corp
NAICS : 325412
SIC : 3741
ISIN : CA82967M1005
Description
Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. The company has a business presence in Canada and France.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | -4.28 | |||||
| Debt-to-Equity | -0.96 | |||||
| Debt-to-EBITDA | -1.48 | |||||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | -88.68 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 20.6 | |||||
| 3-Year EPS without NRI Growth Rate | 20.6 | |||||
| 3-Year FCF Growth Rate | 11.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 49.22 | |||||
| 9-Day RSI | 50.32 | |||||
| 14-Day RSI | 50.08 | |||||
| 6-1 Month Momentum % | 47.46 | |||||
| 12-1 Month Momentum % | -31.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.34 | |||||
| Quick Ratio | 0.34 | |||||
| Cash Ratio | 0.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.9 | |||||
| Shareholder Yield % | -9.6 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | 14518.75 | |||||
| Net Margin % | 16662.5 | |||||
| FCF Margin % | 11483.33 | |||||
| ROA % | -305.38 | |||||
| ROIC % | -266.7 | |||||
| ROC (Joel Greenblatt) % | -33220.59 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -8.9 | |||||
| EV-to-EBITDA | -8.94 | |||||
| EV-to-Revenue | -1256.94 | |||||
| EV-to-FCF | -9.93 | |||||
| Earnings Yield (Greenblatt) % | -11.24 | |||||
| FCF Yield % | -12.04 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sirona Biochem Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | -0.012 | ||
| EPS (TTM) (€) | -0.005 | ||
| Beta | -0.73 | ||
| Volatility % | 106.44 | ||
| 14-Day RSI | 50.08 | ||
| 14-Day ATR (€) | 0.002855 | ||
| 20-Day SMA (€) | 0.040225 | ||
| 12-1 Month Momentum % | -31.82 | ||
| 52-Week Range (€) | 0.01 - 0.087 | ||
| Shares Outstanding (Mil) | 258.84 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sirona Biochem Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sirona Biochem Corp Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sirona Biochem Corp Frequently Asked Questions
What is Sirona Biochem Corp(FRA:ZSB)'s stock price today?
The current price of FRA:ZSB is €0.04. The 52 week high of FRA:ZSB is €0.09 and 52 week low is €0.01.
When is next earnings date of Sirona Biochem Corp(FRA:ZSB)?
The next earnings date of Sirona Biochem Corp(FRA:ZSB) is .
Does Sirona Biochem Corp(FRA:ZSB) pay dividends? If so, how much?
Sirona Biochem Corp(FRA:ZSB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers